GliadinX® Selection of Research Publications
The following publications are only a few among many studies demonstrating the efficacy of Tolerase G®(AN-PEP), the main ingredient in GliadinX®. The current opinion among leading researchers is that it is almost impossible to keep acompletely gluten-free diet without gluten contamination. In case of cross-contamination or accidental gluten ingestion, GliadinX® breaks down the inflammatory gluten molecule quickly and efficiently before it can reach the small intestine.
Some studies are in subscription-based journals and only their abstract is available to the public, but the full text of many studies can be found online. Presently, there are several ongoing studies and we will try to update this page as we become aware of the new publications.
This is the link to the most current study in progress: https://clinicaltrials.gov/ct2/show/NCT04788797
- Gluten Degrading Enzymes for Treatment of Celiac Disease
- Randomised clinical study: Aspergillus niger enzyme digests gluten in the stomach of healthy volunteers
- Challenges in gluten-free diet in coeliac disease: Prague consensus (Up to 50% non-compliance)
- Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: Implications for coeliac disease
- Enzymatic gluten detoxification: the proof of the pudding is in the eating!
- Celiac Disease – Advances in Treatment via Gluten Modification
- Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease
- Degradation of Gluten in Wheat Bran and Bread Drink by Means of a Proline-Specific Peptidase
- Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study
- Reducing Immunoreactivity of Gliadins and Coeliac-Toxi Peptides Using Peptidases from L. acidophilus and A. niger